Company Filing History:
Years Active: 2001-2010
Title: The Innovations of Jian Wu Li
Introduction
Jian Wu Li is a prominent inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of treatments for NF-κB-related conditions. With a total of 4 patents to his name, his work has the potential to impact various therapeutic areas.
Latest Patents
One of Jian Wu Li's latest patents is titled "Double-stranded RNAs directed to IKK-2." This invention provides compositions and methods for treating NF-κB-related conditions. It introduces a stimulus-inducible IKK signalsome, along with its components and variants. This IKK signalsome can be utilized to identify antibodies and other modulating agents that either inhibit or activate signal transduction via the NF-κB cascade. Additionally, these components may be employed in the treatment of diseases associated with NF-κB activation. Another notable patent is "Stimulus-inducible protein kinase complex and methods of use therefor," which shares similar applications and innovations in treating NF-κB-related conditions.
Career Highlights
Jian Wu Li is currently associated with Signal Pharmaceuticals, Inc., where he continues to advance his research and innovations. His work focuses on developing novel therapeutic strategies that leverage the IKK signalsome for medical applications.
Collaborations
Throughout his career, Jian Wu Li has collaborated with notable colleagues, including Frank Mercurio and Hengyi Zhu. These partnerships have fostered a collaborative environment that enhances the research and development of innovative solutions in biotechnology.
Conclusion
Jian Wu Li's contributions to the field of biotechnology through his patents and collaborations highlight his commitment to advancing medical science. His work has the potential to lead to significant breakthroughs in the treatment of NF-κB-related conditions.